Steroid profiling in male wobbler mouse, a model of Amyotrophic Lateral Sclerosis by Gonzalez Deniselle, Maria Claudia et al.
Steroid profiling in male Wobbler mouse, a model of
amyotrophic lateral sclerosis
Maria Claudia Gonzalez Deniselle2,3*, Philippe Liere1*, Antoine Pianos1,
Maria Meyer2, Fanny Aprahamian1, Annie Cambourg1, Noelia P. Di Giorgio4,
Michael Schumacher1, Alejandro F. De Nicola2, Rachida Guennoun1
1 U 1195 Inserm and University Paris-Sud and University Paris Saclay, 80 rue du Général Leclerc, 94276
Kremlin-Bicêtre, France; 2 Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina
Experimental – CONICET, Obligado 2490, 1428 Buenos Aires, Argentina; 3 Depto. de Ciencias
Fisiológicas, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, 1121 Buenos Aires,
Argentina.; 4 Laboratory of Neuroendocrinology, Instituto de Biología y Medicina Experimental –
CONICET, Obligado 2490, 1428 Buenos Aires, Argentina
The Wobbler mouse is an animal model for human motoneuron diseases, especially amyotrophic
lateral sclerosis (ALS), used in the investigation of both pathology and therapeutic treatment. ALS
is a fatal neurodegenerative disease, characterized by the selective and progressive death of mo-
toneurons, leading to progressive paralysis. Previous limited studies have reported steroidal hor-
mone dysregulation in Wobbler mouse and in ALS patients, suggesting endocrine dysfunctions
which may be involved in the pathogenesis of the disease. In this study, we established a steroid
profiling in brain, spinal cord, plasma, adrenal glands and testes in twomonths-old maleWobbler
mice and their littermates by gas chromatography coupled tomass spectrometry. Our results show
inWobblermice i) amarkedupregulationof corticosterone levels in adrenal glands, plasma, spinal
cord regions (cervical, thoracic, lumbar) and brain, ii) a strong decrease in testosterone levels in
testis, plasma, spinal cord and brain, and iii) increased levels of progesterone and especially of its
reduced metabolites 5-dihydroprogesterone, allopregnanolone and 20-dihydroprogesterone
in brain, spinal cord and adrenal glands. Furthermore, Wobbler mice showed a hypothalamic-
pituitary-gonadal hypoactivity. Interestingly, plasma concentrations of corticosterone and testos-
terone correlatewellwith their respective levels in cervical spinal cord inboth control andWobbler
mice. Testosterone downregulation is probably the consequence of adrenal hyperactivity and the
upregulation of progesterone and its reduced metabolites may correspond to an endogenous
protective mechanism in response to motoneuron degeneration. Our findings suggest that in-
creased levels of corticosteroneanddecreased levels of testosterone inplasma couldbea signature
of motoneuron degeneration.
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Abbreviations: 3-HSD: 3-hydroxysteroid dehydrogenase, 3-HSD: 3-hydroxysteroid
dehydrogenase, 5-DHPROG: 5-dihydroprogesterone, 5-DHT: 5-dihydrotestoster-
one, 17-HSD2: 17-hydroxysteroid dehydrogenase type 2, 17-HSD3: 17-hydroxys-
teroid dehydrogenase type 3, 20-DHPROG: 20-dihydroprogesterone, 20-HSD: 20-
hydroxysteroid dehydrogenase, ADIONE: androstenedione, ALS: amyotrophic lateral
sclerosis, AR: androgen receptor, ASAH1: acid ceramidase, CNS: central nervous system,
DHEA: dehydroepiandrosterone, DOC: 11-deoxycorticosterone, GR: glucocorticoid recep-
tor, GC/MS: gas chromatography/mass spectrometry, GnRH: gonadotropin-releasing hor-
mone, HFB: heptafluorobutyrate derivative, HPA: hypothalamo-pituitary-adrenal axis,
HPG: hypothalamo-pituitary-gonadal axis, HPLC: high performance liquid chromatogra-
phy, LH: luteinizing hormone, P450c21: 21-hydroxylase, P450c11: 11-hydroxylase,
P450c17: 17-hydroxylase/17, 20 lyase, P450scc: cholesterol side-chain cleavage, PR:
PROG receptor, PREG: pregnenolone, PROG: progesterone, SDR: short-chain dehydroge-
nases/reductases, SPE: solid phase extraction, TMS: trimethylsilyl derivative.
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ALS is themost commonmotoneuron disease in adultsaffecting motor cortex and spinal cord (1). It is a
progressive and fatal disease leading to death within 3–5
years after theonsetof symptoms resulting fromthe failure
of respiratorymuscles. Themain ALS symptoms are spas-
ticity, hyperreflexia, weakness, paralysis and muscle at-
rophy. Men have a slightly more elevated risk (3:2) to
develop ALS compared to women (2), and the sporadic
form represents the largemajority of cases.Understanding
the pathological mechanisms and the cellular and molec-
ular processes occurring in ALS is a prerequisite for de-
veloping treatments. This can be accomplished by using
and investigating animal models that mimic the patho-
physiology of the disease. The Wobbler mouse has been
used as an animal model of human motoneuron diseases,
especially the sporadic form of ALS, and has contributed
to a better understanding of this complex disease (3, 4).
The Wobbler phenotype is caused by a spontaneous au-
tosomal recessive mutation in the gene encoding the vac-
uolar-vesicular protein sorting factor Vps54 that is a com-
ponent of theGolgi-associated retrogradeprotein (GARP)
complex (5). However, theWobbler pointmutation is not
a complete loss-of-function and the Vps54-null mutation
causes embryonic lethality. This partial mutation desta-
bilizes the Vps54 protein and GARP and leads to retro-
grade vesicle transport impairments, but the link between
GARP dysfunction and motoneuron degeneration is not
clear. Recent data by Dennis and Citron greatly support
the value ofWobblers for ALS research (6). These authors
have demonstrated that Wobbler motoneurons suffer a
relocation of TDP-43 (nuclear transactive DNA-binding
protein) from the nuclear to the cytoplasmic compartment
and changes of ubiquitination commonly found in mo-
toneurons from patients with sporadic forms of ALS.
The disease may be already present in 4-days oldWob-
bler mice (difficulty in righting and astrogliosis in spinal
cord) but it is generally admitted that the presymptomatic
phase comprises the first 3 weeks of postnatal life during
which the Wobbler mice do not present the clinical signs
of the disease. The symptoms develop especially in the
evolutionary phase between 3 weeks and 2–3 months in-
cluding reducedbodyweight and size,motor defects,mus-
cle atrophy and weakness. Degeneration of spinal cord
and brainstem motoneurons, astrogliosis, microgliosis
(7), decreased GABAergic inhibition (8), defects in sper-
miogenesis and male infertility (9) are the main features.
The degeneration ofmotoneurons inWobblermice shows
most of the characteristics of ALS, such as mitochondrial
dysfunction, transport defects, protein aggregation and
cortical hyperexcitability. After 3 months, there is a sta-
bilization of the clinical symptoms.
The higher incidence of ALS in men compared to
women raises the hypothesis of an involvement of sex ste-
roid hormones in the etiopathogenesis of this disorder.
Furthermore, lower plasma testosterone levels (10) and
high levels of plasma cortisol were reported in ALS pa-
tients (11, 12) as well as hypercorticosteronemia in Wob-
bler (13) and in SOD1G93A transgenic mice (14), another
experimental model of familial ALS. All these observa-
tions suggest that endocrine impairment and dysregula-
tion of steroidogenesis could be involved in the pathogen-
esis of ALS. However, in these studies, steroid
measurements were performed only in plasma by using
indirect radioimmunoassays, which are limited by their
specificity and by the analysis of a single steroid.
Gonads and adrenal glands are the major endocrine
sites of steroidogenesis. Steroids are secreted in the blood
and reach target tissueswhere they regulate different func-
tions. Brain and spinal cord are both sources and targets
of steroids. Figure 1 gives an overview of the major ste-
roidogenic pathways in mice involving a set of metabo-
lizing enzymes giving arise to active steroid hormones.
Some pathways are common to different steroidogenic
tissues while others are tissue-specific (15). The first step
in the synthesis of all steroids is the conversion of choles-
terol to pregnenolone (PREG) by the P450scc enzyme.
This step is rate-limiting and hormonally regulated. Ste-
roidogenesis is continually adapted toneeds. For example,
we have measured increased levels of progesterone
(PROG) and its metabolite 5-dihydroprogesterone (5-
DHPROG) in nervous tissues following brain trauma
(16), spinal cord injury (17) and cerebral ischemia (18).
In the central nervous system (CNS), steroids have neu-
roprotective and regenerative actions after injury and dur-
ing neurodegenerative diseases (4, 19). Thus, the neuro-
protective effects of PROG have been shown in models of
injured nervous system and in some neurodegenerative
diseases (4). An apparent dichotomy between neuropro-
tection vs exacerbation of damage was reported for estro-
gens and androgens depending on the context (20, 21).
Chronic elevation of glucocorticoid levels in response to
stress exerts damaging effects on the brain and results in
neurotransmitter dysregulation (22). Hypercorticism also
accompanies many diseases, with negative consequences
for nervous functions (23). In the stressed brain, gluco-
corticoids can exacerbate inflammation (24). In stroke,
high levels of corticosterone are associatedwith highmor-
bidity, impaired functional recovery and ischemic injury
to neurons (25).
Because of the important role steroids play in neuron
viability, the aim of this study was to establish a compar-
ative steroid profiling in control and Wobbler male mice.
We measured PREG, PROG and its reduced metabolites,
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11-deoxycorticosterone (DOC) and corticosterone, dehy-
droepiandrosterone (DHEA), androstenedione (ADI-
ONE), testosterone and 5-dihydrotestosterone (5-
DHT) and 17-estradiol in spinal cord (cervical, thoracic
and lumbar regions), brain, plasma, endocrine glands (tes-
tes and adrenal glands) in order to identify changes in
steroidogenic pathways in symptomatic two months-old
Wobbler mice. For this purpose, we used gas chromatog-
raphy/mass spectrometry (GC/MS), which is the most re-
liable technology for identification and quantification of
steroids present in low amounts within tissues and bio-
logical fluids (26, 27).
Materials and Methods
Animals
A breeding colony of Wobbler mice is established in the an-
imal facility at the Instituto de Biologia y Medicina Experimen-
tal. 10 breeding pairs of heterozygote male and female NFR/wr
mice were used to generate wr/wr mice. For this study a total of
42 control and 35 Wobbler male mice were used. Each mouse
from different litters was identified for its wobbler genotype us-
ing a validated protocol by employing an Alu I restriction poly-
morphism of a Cct4 amplification product for testing the allelic
status at the wr locus (28) (Supplemental Figure 1). Cct4 diag-
nostic primers and restriction enzymes for genotyping were pur-
chased from Promega. Depending on the litters, mice homozy-
gotes for wobbler mutation represent, for example, 1/6, 2/8,
2/10, 2/12 over heterozygotes and controls. The average inci-
dence of the wr/wr genotype in different litters represents 20%.
After genotyping, mice with the desired genotype (homozygotes
for Wobbler mutation and their wildtype littermates) were sac-
rificed and plasma and tissue were collected. Samples were fro-
zen and stocked at –80°C. Analysis was performed when all
samples were collected. Animals were housed in group cages
containing two to three Wobblers and one control mouse. This
social interaction plus supplementing the special nutrient pro-
longs the life span and improves the health status of theWobbler
mice. Mice were kept under conditions of controlled humidity
and temperature (22°C), with lights on from 7:00AM– 7:00 PM
and fed standardmice chowsupplementedwithprotein,mineral,
and vitamin nutrients (Ensure, Abbott, Zwolle, Holland). Ani-
mal procedures followed the guide for the Care and Use of Lab-
oratory Animals (NIH Guide, Insituto de Biologia y Medicina
Experimental Assurance Certificate n° # A5072–01) and were
approved by the Institute’s Animal Care andUse Committee. All
experiments were performed following the ARRIVE guidelines
(www.nc3rs.org.uk).
Samples for steroid measurements
Twomonths-old genotyped symptomaticWobblermalemice
(n  24) showing ambulatory difficulties, muscle atrophy and
forelimb flexion, and control mice (n  26) were killed by de-
capitation in the time range 10.00 AM - 12.00 AM, correspond-
ing to the nadir levels of corticosterone in
rodents and to avoid any potential circa-
dian effects. For eachmouse, blood sam-
ple was taken and the brain, spinal cord,
testes and adrenal glands were dissected
out on a bed of crushed ice. The blood
was centrifuged at 3000g for 10min at
4°C, and the plasmawas collected.Three
segments (cervical, thoracic and lumbar)
were collected from each spinal cord.
Tissues samples were frozen on dry ice,
weighed, and stored at –80°C until gas
chromatography/mass spectrometry
(GC/MS) analysis.
Analysis of steroids by GC/MS
The cervical, thoracic and lumbar re-
gions of spinal cord, brain, testes, adre-
nal glands and plasma from 24Wobbler
and 26 control mice were used. Samples
from 2 different mice were randomly
pooled to obtain sufficient amount of tis-
sue, ie, at least40 to50mg,andofplasma
(at least 100 l) to detect with high pre-
cision all the targeted steroidswith a suit-
able signal-to-noise ratio. After combi-
nation, sample analysis was performed
(n 12 fromWobbler, n 13 from con-
trol mice).
Steroids were extracted from tissues
and plasma with 10 volumes of metha-
Figure 1. Main pathways of steroidogenesis in mice. Steroids are in capital letters with
the following abbreviated names; PREG: pregnenolone, PROG: progesterone, 5-DHPROG: 5-
dihydroprogesterone, 20-DHPROG: 20-dihydroprogesterone, DOC: 11-deoxycorticosterone,
ADIONE: androstenedione, 5-DHT: 5-dihydrotestosterone. Enzymes are indicated in italic with
the following abbreviated names; P450scc: cholesterol side-chain cleavage, 3-HSD: 3-hydroxy-
5-steroid dehydrogenase, 20-HSD: 20-hydroxysteroid dehydrogenase, P450c21: 21-
hydroxylase, P450c11: 11-hydroxylase; P450c17: 17-hydroxylase/17,20 lyase, 17-HSD3:
17-hydroxysteroid dehydrogenase type 3, 17-HSD2: 17-hydroxysteroid dehydrogenase type
2, 3-HSD: 3-hydroxysteroid dehydrogenase, SDR: short-chain dehydrogenases/reductases.
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nol, and internal standards were added for steroid quantifica-
tion: 2ng [2H6]5-DHPROG (CDN Isotopes, Pointe Claire,
Canada) for 5-DHPROG, 2ng 19-norprogesterone (Steraloids,
Newport, Rhode Island) for PROG, 20-DHPROG and allo-
pregnanolone, 2ng of epietiocholanolone for PREG, DHEA and
5-DHT, 2ng [2H5]Testosterone (CDN Isotopes) for testoster-
one and ADIONE, 2ng [2H5]17-estradiol (CDN Isotopes) for
17-estradiol, 2ng [2H8]DOC for DOC (CDN Isotopes) and
10ng [2H8]corticosterone (CDN Isotopes) for corticosterone.
The extraction protocol using methanol and methanol/CHCl3
(1/1) has been described previously (29) and the supernatants
were combined. The first purification step was performed by
solid phase extraction (SPE) using C18 cartridges (500 mg, 6ml;
International Sorbent Technology, Mid Glamorgan, UK). The
simplified recycling/elution protocol was used to separate sul-
fated, unconjugated and fatty acid esters of steroids without
cross-contamination (29). Briefly, sample extracts were dis-
solved in 1ml methanol and applied to the C18 cartridge fol-
lowed by 5ml ofmethanol/water (85/15). The flow-throughwas
collected and dried. After a previous reconditioning of the same
cartridge with 5ml water, samples were dissolved in methanol/
water (2/8) and reapplied. The cartridge was then washed with
5ml water and 5ml methanol/water (1/1) and unconjugated ste-
roidswere elutedwith 5mlmethanol/water (9/1). Then, the frac-
tion containing unconjugated steroids was filtered and further
purified and fractionated by high performance liquid chroma-
tography (HPLC). The HPLC system consisted of a P1000XR
Thermo Separation Product quaternary pump (Thermo Fisher
Scientific, San Jose,CA), anAS100XRThermoSeparationProd-
uct autoinjector andA202modelGilson fraction collector. Sam-
ples were dissolved in hexane/isopropanol (9/1). A Lichrosorb
Diol column (25cm4.6 mm, 5 m)was used in a thermostated
block at 30°C with a mobile phase flow of 1ml/min. The ana-
lytical column was first equilibrated in a solvent system of 90%
hexane and 10% of a mixture hexane/isopropanol (85/15). The
elution was first performed with 90% hexane and 10% hexane/
isopropanol (85/15) for 8min and then with a linear gradient to
100% hexane/isopropanol (85/15) in 2min. This mobile phase
was kept constant for 10min, after which a linear gradient to
100%methanolwas applied. The columnwas rinsedwithmeth-
anol for 15min. Three fractions were collected from the HPLC
system and then derivatized: 1) 5-DHPROG was eluted in the
first fraction (3–13min) and then silylated with 50l MSTFA
(N-methyl-N-trimethylsilyltrifluoroacetamide)/NH4I/DTE
(1000/2/5), for 15min at 70°C, 2) the second fraction (13–
25min) contained PROG, testosterone and their precursors and
metabolites that were derivatized with 25l heptafluorobutyric
anhydride (HFBA) and 25l anhydrous acetone for 1h at 20°C,
3) the third fraction containing corticosterone (25–33min) was
derivatizedwith25l heptafluorobutyric anhydride (HFBA)and
25l anhydrous acetone for 1h at 80°C. All the fractions were
dried under a stream of N2, and then resuspended in hexane for
GC/MS analysis.
Calibrationwas carriedout fromstandards andbiologic sam-
ples were analyzed by GC/MS with an AS 3000 autosampler
(Thermo Fisher Scientific, Waltham, MA). The Focus GC gas
chromatograph was coupled with a DSQII mass spectrometer
(Thermo Fisher Scientific). Injection was performed in the split-
less mode at 250°C (1min splitless time), and the oven temper-
ature of the gas chromatographwas initiallymaintained at 50°C
for 1min, and then ramped to 200°C at 20°C/min, then to 285°C
at 10°C/min, and finally ramped to 350°C at 30°C/min. The
helium carrier gas flow was maintained constant at 1ml/min
during the analysis. The transfer line and ionization chamber
temperatures were 300°C and 220°C, respectively. Electron im-
pact ionization was used for mass spectrometry with ionization
energy of 70 eV. Steroids detection was performed in single ion
monitoring mode and identification was supported by the re-
tention time and two diagnostic ions for each steroid (Supple-
mental Table 1). Steroid quantification was based on the major
diagnostic ion, known as the quantification ion. The GC/MS
analytical procedure was fully validated in terms of identifica-
tion, reproducibility, linearity and precision in the nervous tissue
and plasma of rats (16, 17, 26), mice (18) and humans (30).
Gonadotropin-releasing hormone (GnRH) protein
content determination
For hypothalamic GnRH protein content, the hypothalamus
of control (n  12) and Wobbler (n  7) mice was excised and
rapidly frozen. Tissues were processed as previously described.
Briefly, tissues were homogenized in 200l ice-cold 0.1N HCl,
the homogenate was centrifuged at 13000g at 4°C for 30min,
and the supernatant was recovered. Samples were stored at
–80°C until assayed for GnRH by RIA. GnRH assay sensitivity
was 9.8pg. Intra- and interassay coefficients of variation were
7.1 and 11.6%, respectively (31).
Luteinizing hormone (LH) determination
Trunk blood of control (n  12) and Wobbler (n  7) mice
was collected and sera were obtained and frozen for hormone
determinations. LH protein levels were determined by RIA with
kits fromNHPP, NIDDK&Dr. Parlow. Results were expressed
in terms of RP3 rat LH standards, as these systems recognize
mouse samples. Assay sensitivity: 0.11ng/ml. Intra- and interas-
say coefficients of variation were 7.2 and 11.4% (31).
Statistics
All data are presented as means SEM. Student’s t test were
used for steroid levels comparison in brain, plasma, adrenal
glands and testes, and for hypothalamic GnRH contents, serum
LH levels and weight measurements in Wobbler and control
mice. Two-way ANOVA (genotype x region) followed by Bon-
ferroni post hoc tests were used for the comparison of steroid
levels between spinal cord regions in Wobbler and their litter-
mates. Pearson’s correlation was used to analyze associations
between steroid concentrations in plasma, and cervical spinal
cord and brain in Wobbler and control mice. In all cases, P val-
ues  0.05 were considered statistically significant. Statistical
analyses were performed using GraphPad Prism 4 (GraphPad
Software, Inc., La Jolla, USA).
Results
Two months-old Wobbler male mice exhibited a signifi-
cant decrease in body weight (62% vs controls; P 
.0001). Theweights of different regions of the spinal cord,
brain and testes of Wobbler mice were significantly lower
in comparison to control mice. Only the weight of the
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adrenal glands was similar between the two genotypes
(Table 1).
1. Changes in steroid levels in the cervical, thoracic
and lumbar spinal cord of male Wobbler mice
Steroid profiling in spinal cord regions ofWobbler and
littermate male mice is summarized in Figure 2. Two-way
ANOVA (genotype x region) revealed a significant effect
of the genotype on levels of PREG (F1,68  19.33; P 
.0001), PROG (F1,68  5.477; P  .05), 5-DHPROG
(F1,68  82.2; P  .0001), allopregnanolone (F1,51 
20.02; P  .0001), 20-DHPROG (F1,68 14.17; P 
.001), DOC (F1,69 11.05;P .01), corticosterone (F1,69
 32.57; P .0001), ADIONE (F1,54 16.59; P .001),
testosterone (F1,69  21.06; P  .0001) and 5-DHT
(F1,68 16.58; P .001) in the three regions of the spinal
cord.
In the cervical regionof the spinal cord, Bonferroni post
hoc tests indicated higher levels of 5-DHPROG (x2.9,
P  .001) and corticosterone (x4.3, P  .05) and lower
levels of testosterone (x6.6, P  .05) in Wobbler mice
compared to controls. The concentrations of PREG
(x1.5), PROG (x3.9), 20-DHPROG (x3.4) and DOC
(x3) tended to be higher and that ofADIONE (x3.7) lower
in Wobbler mice but without reaching statistical
significance.
In the thoracic region of spinal cord, Bonferroni post
hoc tests showed a marked increase of the levels of 5-
DHPROG (x3.2, P  .0001), allopregnanolone (x6, P 
.01), 20-DHPROG (x4, P  .01), DOC (x2.1, P  .05)
and corticosterone (x4.3, P .01) and decreased levels of
ADIONE (x2.5,P .01), testosterone (x5.6,P .05) and
5-DHT (x12, P  .05) in Wobbler relative to control
mice. Levels of PREG (x1.5) and PROG (x2) were mod-
erately higher in Wobbler mice compared to control mice
without reaching statistical significance.
In the lumbar region of spinal cord, higher levels of
PREG (x1.7, P  .01), 5-DHPROG (x4.8, P  .0001),
allopregnanolone (x6, P  .0001) and corticosterone
(x4.5,P .01) and lower levels of 5-DHT (x15,P .01)
were measured inWobbler mice comparatively to control
mice. As for the cervical and thoracic regions of spinal
cord, increased levels of PROG (x2.1), 20-DHPROG
(x3.4) and DOC (x1.6) and decreased levels of ADIONE
(x2.1) and testosterone (x11) were measured in Wobbler
mice but the differences were not statistically significant.
In addition to the genotype effect, two-way ANOVA
also indicated a significant region effect on the levels of
PREG (F2,68 5.83; P .01), allopregnanolone (F2,51
3.96; P .05) and DOC (F2,69 3.58; P .05). Bonfer-
roni post hoc tests indicated higher levels of PREG (P 
.05) and allopregnanolone (P .01) in the lumbar region
comparatively to the cervical region of the spinal cord of
Wobbler mice.
2. Changes in steroid levels in the brain of male
Wobbler mice
Steroid profiling was also performed in the brain of
Wobbler mice, characterized by motoneuron degenera-
tion in motor cortex and brainstem.
Data reported in Figure 3 show similar patterns of
changes in steroid levels in the brain ofWobblermice as in
spinal cord regions. Student’s t-tests indicated that brain
concentrations of PREG (x1.6, P  .05), 5-DHPROG
(x4.4, P  .0001), 20-DHPROG (x6.2, P  .01), DOC
(x3.6, P  .01) and corticosterone (x2, P  .01) were
higher, whereas those of androgens such as ADIONE
(x6.5, P .001), testosterone (x7, P .05) and 5-DHT
(x5.5, P .05) were lower in brain ofWobbler male mice
compared to controls. Brain levels of allopregnanolone
were higher in Wobbler mice (x6) albeit no significant
statistical differencewith controlswas founddue toa large
variability in Wobbler mice. It is noteworthy that steroid
levels were in general higher in spinal cord regions than in
brain, especially in Wobbler mice.
3. Changes in steroid levels in plasma of male
Wobbler mice
As for the nervous structures, higher levels 5-DH-
PROG (x3.8, P .001), allopregnanolone (x4, P .01),
20-DHPROG (x5.4, P  .01), DOC (x4, P  .01) and
corticosterone (x3.5,P .01)weremeasured in plasma of
Wobbler mice comparatively to controls. Levels of PROG
(x2.8, P  .055) tended to be higher in Wobbler mice.
Conversely, lower levels of ADIONE (x5.4, P .01) and
testosterone (x14, P  .05) were measured in plasma of
Wobbler mice. Levels of 5-DHT (x2) also tended to be
Table 1. Weights of mice, brain, spinal cord regions,
testis and adrenal glands of control (n  13) and
Wobbler (n  12) male mice. Data are expressed as
means  SEM Statistical analysis: Student t test, *P 




Mice 28.52  0.21 10.85  0.66****
mg  SEM
Brain 342.4  2.98 236.3  3.83****
Cervical 36.38  1.53 26.58  3.19*
Thoracic 28.78  1.33 22.18  2.35*
Lumbar 41.11  1.08 26.51  2.15****
Testis 165.4  2.53 83.44  7.82****
Adrenal glands 9.15  0.76 8.31  0.43
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lower but the difference did not reach statistical signifi-
cance (Figure 4).
4. Dysregulation of the hypothalamo-pituitary-
gonadal (HPG) axis in male Wobbler mice
The steroid status was evaluated in testis to assess a
possible impairmentof testosteronebiosynthesis inLeydig
cells in Wobbler mice. Figure 5
shows clearly that testosterone syn-
thesis is impaired in Wobbler mice.
Testosterone concentrations were
11-fold lower inWobbler testis (P
.05) aswell as its precursorADIONE
(x8, P  .01) and metabolite 5-
DHT (x7, P .05) comparatively to
controlmice.Conversely, corticoste-
rone levels were higher in testis of
Wobbler (P  .01) as compared to
control mice. PROG, 5-DHPROG
and 20-DHPROG levels were also
increased in testis of Wobbler mice
(x5, x6 and x3-fold, respectively),
without however reaching statistical
significance.
In order to go further in the anal-
ysis of testosterone synthesis defi-
ciency, the levels of GnRH in hypo-
thalamus and of the LH
gonadotropin in serum were also
measured. Our data show a reduc-
tion in levels of GnRH (54.6 
7.5pg/mg in Wobblers (n  7) vs
107.6 7.57pg/mg in controls (n
12); P  .01) and LH (0.44 
0.12ng/ml in Wobblers (n  11) vs
1.14  0.23ng/ml in controls (n 
18); P  .05) in Wobbler mice. The
histological analysis of testis showed
deficits in spermiogenesis, gaps be-
tween Sertoli cells and germ cells,
and reduction in size of Leydig cells
(Supplemental Figure 2).
5. Changes in steroid levels in
the adrenal glands of male
Wobbler mice
Steroid measurements were also
performed in adrenal glands to in-
vestigate if hypercorticosteronemia
observed in CNS and plasma came
from adrenal stimulation due to a
dysfunction of the hypothalamic-pi-
tuitary-adrenals (HPA) axis inWob-
bler mice. Steroid analysis showed a
very strong stimulationof corticoste-
Figure 2. Steroid profiling in cervical, thoracic and lumbar regions of spinal
cord of control and Wobbler male mice. PREG: pregnenolone, PROG: progesterone, 5-
DHPROG: 5-dihydroprogesterone, 20-DHPROG: 20-dihydroprogesterone, DOC: 11-
deoxycorticosterone, ADIONE: androstenedione, 5-DHT: 5-dihydrotestosterone. Steroid
concentrations are expressed as ng/g  SEM. White bars: control mice (CTL, n  13), black bars:
Wobbler mice (WB, n  12). Statistical analysis: two-way ANOVA (genotype x spinal cord region)
followed by Bonferroni post hoc tests. *, P  .05; **, P  .01, ***, P  .001, ****, P  .0001.
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rone biosynthesis in adrenal glands ofWobbler mice (Fig-
ure 6). Levels of corticosterone rose from 12.13 g/g in
control to 60.67 g/g (x5, P  .01) in Wobbler adrenal
glands. These results were supported by the significantly
increased levels of adrenal corticosterone precursors,
PREG (x3.5,P .05), PROG (x5.5,P .0001) andDOC
(x3, P  .01) as well as the PROG
metabolite, 20-DHPROG (x20,
P .05), in Wobbler adrenal glands
comparatively to controls. Allopreg-
nanolone levels were slightly higher
(x2) in Wobbler, but this difference
was not statistically significant. As
for the other tissues, testosterone
level was significantly diminished in
Wobbler adrenals (P .01). Finally,
levels of 5-DHPROG, ADIONE
and 5-DHT were similar in Wob-
bler relatively to control mice.
The adrenal gland of Wobbler
mice showed different signs of hy-
pertrophy. Indeed, the ratio of adre-
nal gland weight/body weight was
higher in Wobbler mice compara-
tively to controls P .001) (Supple-
mental Figure 3A). The histological
analysis of adrenal cortex revealed
some foci of cells with increased size
in zona Fasciculata of Wobbler mice
(Supplementary Figure 3B4 and 3C)
as compared to control mice (Sup-
plementary Figure 3B3 and 3C).
DHEA and 17-estradiol were
systematically searched for, butwere
not detected in all the tissues inves-
tigated. The limits of detection of
DHEA and 17-estradiol were
20pg/g in tissues and 20pg/ml in
plasma.
6. Correlations between
steroids levels in plasma and
the cervical region of the spinal
cord and brain
Pearson’s correlations between
steroids levels in plasma and the cer-
vical region of the spinal cord and
brain were performed in order to as-
sess if plasmatic steroids could re-
flect levels in the CNS, where mo-
toneuron degeneration occurs.
Strong positive correlations were
found for corticosterone and testos-
terone between their levels in plasma
and in the cervical region of the spi-
Figure 3. Steroid profiling in brain of control and Wobbler male mice. PREG:
pregnenolone, PROG: progesterone, 5-DHPROG: 5-dihydroprogesterone, 20-DHPROG: 20-
dihydroprogesterone, DOC: 11-deoxycorticosterone, ADIONE: androstenedione, 5-DHT: 5-
dihydrotestosterone. Steroid concentrations are expressed as ng/g  SEM. White bars: control
mice (CTL, n  13), black bars: Wobbler mice (WB, n  12). Statistical analysis: Student’s t test.
*, P  .05; **, P  .01, ***, P  .001.
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nal cord in both control andWobbler mice (Table 2). The
slopes of the lines were similar in controls and Wobbler
mice. In addition, positive correlationswere also found for
PREG and 5-DHPROG levels in plasma and cervical
region of spinal cord of Wobbler
mice only (Table 2). Pearson’s cor-
relation between steroid concentra-
tions in plasma and brain indicated
strong positive associations for 5-
DHPROG and testosterone levels in
control mice and for corticosterone
specifically in Wobbler mice.
Discussion
In this study, we have demonstrated
marked changes in steroid levels in
maleWobblermice, an experimental
model of ALS. Steroid profiling per-
formed by GC/MS in brain and spi-
nal cord regions, plasma and endo-
crine glands, revealed particular
steroid patterns in symptomatic
Wobbler mice as compared to their
control littermates: upregulation of
progesterone and its reduced metab-
olites and of corticosteroids, and
downregulation of androgens. In ad-
dition, we have shown positive cor-
relations between plasma and cervi-
cal spinal cord levels of
corticosterone and testosterone both
in control andWobbler mice. Taken
together, these findings suggest that
increased levels of corticosterone
and decreased levels of testosterone
in plasma could be a signature of the
motoneuron disease process.
As expected, the size and weight
of Wobbler male mice were lower
than their control littermates. These
reductions starts at the third to the
fourthweekandpersists to the endof
the life (3, 5, 32). It has been pro-
posed that it may partially result
from nutritional deprivation, prob-
ably linked to muscle atrophy in the
face and forelimbs (33). Our results
suggest that the elevated endogenous
levels of glucocorticosteroids may
also contribute to the reduced body
weight. Indeed, chronic high levels of
corticoids have been shown to result
Figure 4. Steroid profiling in plasma of control and Wobbler male mice. PREG:
pregnenolone, PROG: progesterone, 5-DHPROG: 5-dihydroprogesterone, 20-DHPROG: 20-
dihydroprogesterone, DOC: 11-deoxycorticosterone, ADIONE: androstenedione, 5-DHT: 5-
dihydrotestosterone. Steroid concentrations are expressed as ng/ml  SEM. White bars: control
mice (CTL, n  13), black bars: Wobbler mice (WB, n  12). Statistical analysis: Student’s t test.
*, P  .05; **, P  .01, ***, P  .001.
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in decreased body weight (34) by decreasing food intake
via inhibition of ghrelin synthesis and an increase in leptin
levels (35, 36). In addition, the low levels of androgens in
Wobblers may also contribute to body weight loss and a
decrease in muscle strength in Wobbler mice. The high
levels of corticosterone and low levels of androgens may
also explain in part the decreased
weights of brain and spinal cord,
wheremotoneuron degeneration oc-
curs, and of the testes of Wobblers
characterizedby impaired spermato-
genesis and infertility (9). Interest-
ingly, although not as marked as in
Wobblermice, brain volume loss has
also been reported for patients with
ALS, suggesting that ALS may be a
degenerative disease not confined to
motor systems (37).
Upregulation of PREG, PROG
and its metabolites in the
Wobbler CNS: a possible
endogenous neuroprotective
response to neurodegeneration
TheCNS is both a site of synthesis
and a target for steroids. Thus, ste-
roid amounts present in the nervous
system result from both the endo-
crine glands and local synthesis. The
higher amounts of PREG measured
in theWobbler spinal cord and brain
when compared to plasma levels
may reflect an increase in local syn-
thesis. PROG levels were signifi-
cantly enhanced only in the spinal
cord and not in brain of Wobbler
mice as compared to control.A series
of arguments indicate that the adre-
nal glands may significantly contrib-
ute to the increase of PROG in spinal
cord. Indeed, i) PROG levels in spi-
nal cord and plasma were in equilib-
rium, ii) PROG levels were higher in
plasma of Wobbler relative to con-
trol mice, and iii) PROG levels were
also strongly higher in adrenal
glands of Wobbler mice. High levels
of 5-DHPROG, about 5-times
higher than in plasma, were ob-
served in the Wobbler spinal cord.
Consistently, the accumulation of
5-reduced metabolites (5-DH-
PROG and allopregnanolone) was
also markedly increased in theWob-
bler brain, pointing to a strong 5-
Figure 5. Steroid profiling in testis of control and Wobbler male mice. PREG:
pregnenolone, PROG: progesterone, 5-DHPROG: 5-dihydroprogesterone, 20-DHPROG: 20-
dihydroprogesterone, DOC: 11-deoxycorticosterone, ADIONE: androstenedione, 5-DHT: 5-
dihydrotestosterone. Steroid concentrations are expressed as ng/g  SEM. White bars: control
mice (CTL, n  13), black bars: Wobbler mice (WBL, n  12). Statistical analysis: Student’s t test.
*, P  .05; **, P  .01.
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reductase activity in the CNS. Interestingly, levels of al-
lopregnanolone, a metabolite which also exerts
neuroprotective effects, were only increased in the brain
and the thoracic and lumbar regions of the spinal cord, but
not in the cervical part where motoneurons degenerate.
Upregulation of PREG, PROG and especially its re-
duced metabolites in CNS may be a
part of protective, rescue or even re-
generative processes in response to
neurodegenerationor injury (19). In-
deed, brain and spinal cord levels of
PREG, PROG and 5-DHPROG,
are markedly upregulated in re-
sponse to traumatic brain injury
(TBI) (16), cerebral ischemia (18),
and spinal cord transection (17).
Neuroprotective effects of PROG
and allopregnanolone have been
demonstrated in many injury mod-
els, including stroke (38), excito-
toxic damage of hippocampal neu-
rons (39), traumatic spinal cord
injury (4), and in mouse models of
spontaneous spinal motoneuron de-
generation, Niemann-Pick type C
disease andAlzheimer’s disease (40–
42). According to a widely accepted
concept, the neuroprotective effects
of PROGmay bemediated by itsme-
tabolite allopregnanolone, but re-
cent studies have shown that the in-
tracellular PROG receptors (PR)
play a crucial role in both the neuro-
protective and remyelinating actions
of PROG (18, 43, 44).
Importantly, previous reports
have shown that PROG could par-
tially restore morphological, molec-
ular and functional abnormalities in
Wobbler mice. PROG was able to
rescue motoneurons from degenera-
tion by recovering histopathological
abnormalities and mRNA expres-
sion of the sodiumpump (45), block-
ingNOsynthesis andoxidativedam-
age (46), improving neuromuscular
function (47), modulating BDNF
and choline acetyltransferase (48,
49), improving motoneuron and
glial cell abnormalities (50) and pre-
venting mitochondrial dysfunction
(51). Nestorone, a PR agonist with
high-affinity and high-specificity for
PR, decreased astrogliosis, micro-
gliosis, and motoneuron degenera-
Figure 6. Steroid profiling in adrenal glands of control and Wobbler male mice.
PREG: pregnenolone, PROG: progesterone, 5-DHPROG: 5-dihydroprogesterone,
20-DHPROG: 20-dihydroprogesterone, DOC: 11-deoxycorticosterone, ADIONE:
androstenedione, 5-DHT: 5-dihydrotestosterone. Steroid concentrations are expressed as ng/
g  SEM. White bars: control mice (CTL, n  13), black bars: Wobbler mice (WB, n  12).
Statistical analysis: Student’s t test. *, P  .05; **, P  .01, ****, P  .0001.
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tion in Wobbler mice (52). PROG also delayed neurode-
generative processes and prolonged lifespan in transgenic
mice expressing the human G93-SOD1 mutant, a genetic
ALS model, via activation of an autophagy pathway (53).
Interestingly, endogenous levels of PROGwere also found
to correlate positively with factors predicting better prog-
nosis and survival in ALS patients (54).
PROG can also be converted to 20-DHPROG. 20-
reduction represents a competitivemetabolic pathway rel-
atively to the 5-reduction (55). 20-DHPROG levels
were increased in brain, spinal cord, plasma, testis, and
adrenal glands of Wobbler mice. 20-DHPROG can be
formed in several tissues such as adrenal glands and liver
and can also be synthesized in the brain of rats (56) and
mice (57). Notably in mice, the expression of the 20-
hydroxysteroid dehydrogenase (20-HSD) was observed
in cerebral cortex and hippocampus, and it has been sug-
gested that 20-HSD might regulate the availability of
PROG for PR and for the formation of neuroactive me-
tabolites by the 5-reductases (57). Levels of 20-DH-
PROG were increased by 20-fold in the adrenal glands of
Wobbler mice, probably as a consequence of a chronic
stress as suggested by Higashi et al (58).
Upregulation of corticosterone: a possible
contribution to motoneuron degeneration in
Wobbler mice
We have shown a marked increase in corticosterone
levels, as well as in its precursor DOC, in brain, spinal
cord, plasma, and adrenal glands of Wobbler relative to
control mice. These results confirm and extend the results
of previous studies showing higher corticosterone levels in
plasma ofWobbler (13), and of SOD1G93Amice (14). Fur-
thermore, Fidler and al. showed that corticosterone levels
correlated negatively with the onset of paralysis and sur-
vival in SOD1G93A mice. Importantly, these mice exhib-
ited acceleration of the disease progression and of several
neuropathological features such as astrogliosis,microglial
activation and motor function decline when submitted to
a repeated restraint-induced stress condition (14). Here,
we show that in addition to plasma, all the regions of the
spinal cord and brain contain higher amounts of cortico-
sterone in Wobbler mice as compared with their litter-
mates, most likely resulting from adrenal gland hyperac-
tivity and hypertrophy of zona fasciculata.
Several reports have demonstrated a marked dysfunc-
tion of the HPA axis in ALS patients that may aggravate
motoneuron degeneration. Thus, a loss of cortisol circa-
dian rhythm, an increase in saliva cortisol in the morning
and evening and decreased response to stress have been
reported (11).Other studies have reportedhighermorning
levels of cortisol in patients with the sporadic form of ALS
(54) and Roozendaal et al have shown a blunted cortisol
awakening response correlating with ALS severity (59).
Furthermore, there is an increased risk for developingALS
in individuals exposed topsychological andphysical stress
(60) and an accelerated functional decline and shorter
lifespan in individuals displaying high levels of psycho-
logical distress (61). Thus, differences in the exposure to
stressful events may account for the variability observed
between the ALS patients in terms of disease time course
and survival.
The link between corticoids and neurodegeneration is
corroborated by several reports showing HPA hyperac-
tivity in other neurological disorders such as Alzheimer’s
disease, vascular dementia (62) and Huntington’s disease
(63). Therefore, it is not surprising that in addition to
spinal cord and brain stem pathology, hippocampal ab-
normalities are found inALSpatients (64), triggeredby the
Table 2. Pearson’s correlation (r value) and slope of the line of steroid levels in plasma vs. cervical spinal cord and
brain in control (n  13) and Wobbler (n  12) male mice. PREG: pregnenolone, PROG: progesterone, 5-DHPROG:
5-dihydroprogesterone. ns: not significant. *P  0.05 **P  0.01 ***P  0.001 ****P  0.0001
Cervical Brain




0.67* (2.07) 0.43 ns (0.85) 0.02 ns (0.05)
PROG 0.32 ns (-0.83) 0.09 ns (-2.11) 0.27 ns (4.64) 0.55 ns (0.98)
5-DHPROG 0.51 ns (3.35) 0.66* (3.03) 0.87***
(1.32)
0.42 ns (0.97)
Allopregnanolone 0.18 ns (-0.32) 0.22 ns (-0.16) 0.42 ns (-
0.02)
0.50 ns (0.27)
Corticosterone 0.65* (0.34) 0.66* (0.31) 0.46 ns (0.30) 0.82** (0.11)
Testosterone 0.99**** (0.75) 0.85* (0.94) 0.96****
(0.72)
0.38 ns (-0.42)
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hyperactivity of the glucocorticoids receptor (GR). This
hypothesis is based on central glucocorticoid action on
hippocampal morphology and function, where a severe
and/or prolonged stress can mediate deleterious effects
(65). Similarly,Wobblermice also present a dysfunctional
hippocampus (66). By using a selective and high affinity
GRantagonist, a recent study has shown that blocking the
GR increasedneuronal progenitors, decreased astrogliosis
andmodifiedmicroglial phenotype in the hippocampus of
Wobbler mice treated with corticosterone (13).
A potential mechanism of the adrenal dysfunction in
Wobbler mice and ALS patients might be linked to an
impairment of the acid ceramidase (ASAH1). Indeed,
ASAH1suppression increased the transcriptionof adrenal
genes involved in steroidogenesis, and ASAH1 is a main
inhibitor of steroidogenic capacity in human adrenal cor-
tex (67). Furthermore, mutations in ASAH1 have been
associated with spinal cord atrophy-progressive myoclo-
nic epilepsy (SMA-PME), an inherited neuromuscular dis-
order characterized by degeneration of motoneurons in
the spinal cord and leading to progressive atrophy of skel-
etal muscles and paralysis (68).
Dysregulation of HPG axis in male Wobbler mice
We also showed an important deficiency of androgen
synthesis in the testes of Wobbler mice. Indeed, testoster-
one levels, as well as its precursor ADIONE and its me-
tabolite 5-DHTweremarkedly decreased in testis. A 10-
fold drop in testosterone levels was also observed in
plasma and CNS tissues. The size of Leydig cells as well as
GnRH and LH levels were also significantly decreased in
Wobblermice, demonstratingdysregulations at all the lev-
els of HPG axis. These results are consistent with the de-
fects of spermiogenesis and sterility observed in Wobbler
mice (9). A decrease in testosterone levels, measured by
RIA, was reported in serum of ALS patients of both sexes
(10), suggesting a possible involvement of androgens in
the pathophysiology of the motoneuron disease. How-
ever, a recent study using immunoradiometric kits did not
show a decline in testosterone levels with increasing age in
ALS men (69). Thus, analysis of steroids in ALS patients
using mass spectrometric techniques is needed.
The cross-talk between the HPA and HPG axes could
contribute to the important changes in steroid levels ob-
served in Wobbler mice. Several studies have focused on
the mechanisms by which stress disrupts reproductive
functions (70, 71). The adrenal axis, stress and high doses
of glucocorticoids disrupt all aspects of the HPG axis,
including reproductivebehavior, LHsecretionand sex ste-
roid synthesis and release (70, 71). Thus, the high levels of
corticosterone secreted by the adrenals of the Wobbler
mice may explain, at least partially, the marked decrease
inGnRH, LHand androgens. It is noteworthy that several
components of the gonadal axis can also affect the HPA
axis. Indeed, it iswell known that androgens act negatively
at several levels of the HPA axis, including hypothalamic
CRH, pituitary ACTH and adrenal glucocorticoids, This
effect is mainly mediated by the AR in multiple brain re-
gions (72).
In addition to the cross-talk between HPG and HPA
axes, a common dysregulation at the hypothalamus-pitu-
itary levels and/or at the steroidogenic gland level could
also be considered in Wobbler mice. Indeed, given the
reduced levels of both LH and testosterone in Wobbler
mice, it could be expected that GnRH levels will markedly
increase. The observed decreased level of GnRH in our
study suggest a probable dysregulation at the central level.
It is conceivable that the Golgi defects in Wobbler mice
may cause altered synthesis, trafficking or release of hy-
pothalamic CRH and GnRH and of gonadotropins as the
Golgi apparatus is important for the intracellular vesicular
transport and is localized at the center of the secretary
pathway. Besides, steroid hormone production in endo-
crine glands is amultistep process including the regulation
of cholesterol uptakeand transport aswell as the transport
of steroid substrates between the endoplasmic reticulum
and the mitochondria. The cytoskeleton such as micro-
filaments and microtubules as well as a protein complex
called “transducesome” (19) play a key role in assuring an
efficient processing and transport of cholesterol in steroid-
ogenic cells. Thus, defects in Golgi apparatus and mito-
chondria, as reported inWobbler mice, could easily cause
steroidogenesis dysfunctions in this context. Importantly,
a recent publication by Xu et al (73) showed that a Golgi-
localized membrane protein progestin and adipoQ recep-
tors 3 (PAQR3) regulates cholesterol homeostasis by an-
choring specific transcription factors to the Golgi
apparatus. Thus, theWobbler mutation, bymeans of par-
tial loss of function of Vps54 and GARP, may cause a
dysregulation of GnRH and LH synthesis/release and of
cholesterol homeostasis and steroidogenesis in steroido-
genic cells.
There is male predominance in ALSwith a gender ratio
of 3:2, but this sex differences is age-dependent (74). A
hormonal factor has been suspected to play a role in the
higher incidence of the disease in males. Several lines of
evidence indeed point to an association between dysfunc-
tions in androgen signaling and motoneuron degenera-
tion. For example, the spinal andbulbarmuscular atrophy
(SBMA) is a genetic pathologydue toanARmutationwith
signs of androgen insensitivity, and is characterized by
motoneuron degeneration and endocrine abnormalities
(75). In a mouse model of SBMA, castration of males re-
duced muscular atrophy and weakness and testosterone
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administration in females markedly increased the symp-
toms (76). The use of synthetic anabolic substances has
been suspected to contribute to an increased risk of ALS in
soccer players (60). The use of nandrolone decanoate, an
anabolic androgenic steroid, in SOD1G93A mice led to
muscle hypertrophy but also to motoneurons death and
shorter survival of the treated mice (77). Treatment with
nandrolone induced the recruitment of AR into insoluble
complexes, pointing to an important role of AR homeo-
stasis in the pathogenesis of motoneurons. However, two
recent studies using the SOD1G93A mice have shown
myotrophic and neuroprotective effects of 5-DHT (78)
and preventive effects of nandrolone on the structural al-
terations of the neuromuscular junctions (79).
The question of sex specificity needs to be addressed in
Wobbler mice. Indeed, Wobbler females are infertile (3).
Surprisingly, unlike for males, no reviews (except the one
cited above) mention this fact and no studies have been
undertaken to explain this infertility. Indeed, there are no
studies concerning Wobbler female mice fertility, game-
togenesis, and regularity of cycles or steroidogenesis.
Given our present results in males, it is likely that game-
togenesis, steroidogenesis and the HPG axis are also af-
fected in Wobbler females.
As expected, the levels of DHEA were below the level
of detection of GCMS in all tissue and plasma samples.
Indeed, rodents utilize 17alpha-hydroxyprogesterone as
substrate yielding androstenedione as product in the con-
trary of human P450C17 enzyme which uses 17alpha-
hydroxypregnenolone as substrate yielding DHEA as
product. This is also consistent with recent results by Son-
dhi et alwho showed that levels ofDHEA inmicewere less
than 20pg/ml (80). However, some reports detected mea-
surable low amounts of DHEA in rat brain (81). The dis-
crepancies might relate to strain or technical procedures.
Cholesterol indeed can be oxidized readily during the en-
tire sample workup, and can give rise, under particular
conditions to DHEA. Thus, the different steps of purifi-
cation and fractionation upstream of steroid measure-
ments are very important to consider as we have already
discussed in previous papers (27, 29).
Increased levels of corticosterone and decreased
levels of testosterone in plasma: a signature of
motoneuron degeneration?
The search for plasma biomarkers is important for
monitoring disease progression and assessing treatment
efficacy in animal models as well as in ALS patients.
Changes in circulating glucocorticoids and androgens
may influence the time course of the disease by preventing
and/or acceleratingmotoneuron degeneration inWobbler
mice. In wildtype andWobbler mice, no correlation exists
for PROG and allopregnanolone between their plasma
and spinal cord and brain levels. Conversely, plasma and
cervical spinal cord corticosterone and testosterone con-
tents are well correlated. Our findings show that cortico-
sterone levels are increased and testosterone levels de-
creased in Wobbler mice compared to controls, and their
levels in plasma reflect their amounts in spinal cord. It will
be important to conduct longitudinal studies for assessing
the evolution of plasma levels of steroids in experimental
ALSmodels andALS patients. These data will be useful to
identify the onset of endocrine dysfunctions and to adapt
treatment strategies to ameliorate the pathological fea-
tures of motoneuron diseases.
Conclusion
Our study highlights marked changes in steroid levels in
the symptomatic male Wobbler mouse, a model of ALS,
with an upregulation of adrenal glucocorticoids and a
downregulation of testicular androgens. HPA hyperactiv-
ity in Wobbler mice, also observed in other models of
neurodegenerative disorders, possibly results from
chronic stress exposure resulting from the disease process
and disturbed central glucocorticoid feedback pathways.
We suggest that hypercorticosteronemia may accelerate
several pathological features such as motoneuron degen-
eration in cortex, brainstem and spinal cord, as well as
astrogliosis andmicroglial hyperactivity. Thus, regulators
of glucocorticoid signaling pathways could be useful for
ameliorating the pathological features of ALS. On the
other hand, the upregulation of PROG and its reduced
metabolites in CNS ofWobbler may participate in endog-
enous neuroprotective and rescue mechanisms. Our re-
sults demonstrate a reduction in androgen levels in Wob-
bler mice. The precise role of androgen deficiency in the
degeneration of motoneurons in Wobbler mice and ALS
patients warrants further investigations; a dysregulation
of androgen signaling has been shown to be associated
with motoneuron diseases.
To conclude, our findings 1) underline the interdepen-
dence between the nervous system and endocrine system,
2) suggest that a combined rather than a single steroid
therapy will be required to treat the consequences of the
steroid imbalance, and 3) provide some keys for develop-
ing novel therapeutic approaches based on progesterone,
glucocorticoid modulators and androgens to ameliorate
the ALS pathogenesis. In addition, increased levels of cor-
ticosterone and decreased levels of androgens in plasma
could be a signature of motoneuron degeneration. Steroid
profiling may thus be used as a potential biomarker for
degenerative diseases of motoneurons.
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